JP2004154120A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004154120A5 JP2004154120A5 JP2003002091A JP2003002091A JP2004154120A5 JP 2004154120 A5 JP2004154120 A5 JP 2004154120A5 JP 2003002091 A JP2003002091 A JP 2003002091A JP 2003002091 A JP2003002091 A JP 2003002091A JP 2004154120 A5 JP2004154120 A5 JP 2004154120A5
- Authority
- JP
- Japan
- Prior art keywords
- gene
- gene polypeptide
- activity
- polypeptide
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 description 18
- 229920001184 polypeptide Polymers 0.000 description 12
- 108090000765 processed proteins & peptides Proteins 0.000 description 12
- 102000004196 processed proteins & peptides Human genes 0.000 description 12
- 238000000034 method Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000002157 polynucleotide Substances 0.000 description 6
- 102000040430 polynucleotide Human genes 0.000 description 6
- 108091033319 polynucleotide Proteins 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 101100379079 Emericella variicolor andA gene Proteins 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229940124606 potential therapeutic agent Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02000153 | 2002-01-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004154120A JP2004154120A (ja) | 2004-06-03 |
| JP2004154120A5 true JP2004154120A5 (enExample) | 2006-02-23 |
Family
ID=8185191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003002091A Pending JP2004154120A (ja) | 2002-01-08 | 2003-01-08 | 心血管疾患を予測する一塩基多型および治療効果 |
Country Status (4)
| Country | Link |
|---|---|
| EP (2) | EP1978108A3 (enExample) |
| JP (1) | JP2004154120A (enExample) |
| AU (1) | AU2003201159A1 (enExample) |
| WO (1) | WO2003057911A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0304660A (pt) | 2002-05-01 | 2005-06-07 | Schering Ag | Anticorpos direcionados a fator de tecido como anticoagulantes |
| EP2186913B1 (en) * | 2003-11-26 | 2016-02-10 | Celera Corporation | Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof |
| CA2573945A1 (en) * | 2004-07-16 | 2006-01-26 | Bayer Healthcare Ag | Single nucleotide polymorphisms as prognostic tool to diagnose adverse drug reactions (adr) and drug efficacy |
| AU2006261555A1 (en) * | 2005-06-23 | 2006-12-28 | The University Of British Columbia | Coagulation factor lll polymorphisms associated with prediction of subject outcome and response to therapy |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4491632A (en) | 1979-10-22 | 1985-01-01 | The Massachusetts General Hospital | Process for producing antibodies to hepatitis virus and cell lines therefor |
| US4444887A (en) | 1979-12-10 | 1984-04-24 | Sloan-Kettering Institute | Process for making human antibody producing B-lymphocytes |
| DE3167442D1 (en) | 1980-07-07 | 1985-01-10 | Nat Res Dev | Improvements in or relating to cell lines |
| US4341761A (en) | 1980-07-25 | 1982-07-27 | E. I. Du Pont De Nemours And Company | Antibodies to immunogenic peptides and their use to purify human fibroblast interferon |
| US4466917A (en) | 1981-02-12 | 1984-08-21 | New York University | Malaria vaccine |
| US4493890A (en) | 1981-03-23 | 1985-01-15 | Miles Laboratories, Inc. | Activated apoglucose oxidase and its use in specific binding assays |
| US4399121A (en) | 1981-11-04 | 1983-08-16 | Miles Laboratories, Inc. | Iodothyronine immunogens and antibodies |
| US4427783A (en) | 1981-12-14 | 1984-01-24 | Hoffmann-La Roche Inc. | Immunoassay of thymosin α1 |
| GB8311018D0 (en) | 1983-04-22 | 1983-05-25 | Amersham Int Plc | Detecting mutations in dna |
| US4998617A (en) | 1986-09-15 | 1991-03-12 | Laura Lupton Inc | Facial cosmetic liquid make up kit |
| FR2650840B1 (fr) | 1989-08-11 | 1991-11-29 | Bertin & Cie | Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications |
| ATE162631T1 (de) | 1989-11-13 | 1998-02-15 | Childrens Medical Center | Ein nichtinvasives verfahren zur trennung und zum nachweis von fetaler dna |
| US6004744A (en) | 1991-03-05 | 1999-12-21 | Molecular Tool, Inc. | Method for determining nucleotide identity through extension of immobilized primer |
| DE69322266T2 (de) | 1992-04-03 | 1999-06-02 | Perkin-Elmer Corp., Foster City, Calif. | Proben zusammensetzung und verfahren |
| DE69433811T2 (de) | 1993-01-07 | 2005-06-23 | Sequenom, Inc., San Diego | Dns - sequenzierung durch massenspektronomie |
| US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
| DE69430909T2 (de) | 1993-03-19 | 2003-02-27 | Sequenom, Inc. | Dns-sequenzbestimmung durch massenspektrometrie auf dem weg des abbaus mit exonuklease |
| US5593826A (en) | 1993-03-22 | 1997-01-14 | Perkin-Elmer Corporation, Applied Biosystems, Inc. | Enzymatic ligation of 3'amino-substituted oligonucleotides |
| US5571676A (en) | 1995-06-07 | 1996-11-05 | Ig Laboratories, Inc. | Method for mismatch-directed in vitro DNA sequencing |
| CZ228598A3 (cs) | 1996-01-23 | 1998-12-16 | Rapigene, Inc. | Způsoby a kompozice pro analyzování molekul nukleových kyselin za použití postupu třídění |
| GB9620209D0 (en) | 1996-09-27 | 1996-11-13 | Cemu Bioteknik Ab | Method of sequencing DNA |
| EP1136554A1 (en) * | 2000-03-24 | 2001-09-26 | Bayer Aktiengesellschaft | ATP binding cassette transporter 1 (ABC1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases |
| WO2001079234A2 (en) * | 2000-04-14 | 2001-10-25 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the apoe gene |
| CA2409774A1 (en) * | 2000-05-23 | 2001-11-29 | Variagenics, Inc. | Methods for genetic analysis of dna to detect sequence variances |
| WO2008042762A2 (en) * | 2006-09-29 | 2008-04-10 | The Cleveland Clinic Foundation | Single nucleotide polymorphisms associated with cardiovascular disease |
-
2003
- 2003-01-07 EP EP08006507A patent/EP1978108A3/en not_active Withdrawn
- 2003-01-07 EP EP03729224A patent/EP1465998A2/en not_active Ceased
- 2003-01-07 AU AU2003201159A patent/AU2003201159A1/en not_active Abandoned
- 2003-01-07 WO PCT/EP2003/000060 patent/WO2003057911A2/en not_active Ceased
- 2003-01-08 JP JP2003002091A patent/JP2004154120A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6316994B2 (ja) | 心筋梗塞に関連する遺伝的多型、その検出方法および使用 | |
| WO2010019550A4 (en) | Method of identifying disease risk factors | |
| NO20100798L (no) | Polymorfismer i det humane MDR-1-genet og deres diagnostiske og terapeutiske anvendelse | |
| CN103374575B (zh) | Cyp4v2基因突变体及其应用 | |
| JP2006518186A5 (enExample) | ||
| US20110223593A1 (en) | Predicting a response to olanzapine | |
| JP2004154120A5 (enExample) | ||
| JP2004533848A5 (enExample) | ||
| WO2005086872A2 (en) | Ptpn22 polymorphisms in diagnosis and therapy | |
| KR101046344B1 (ko) | Ｓｎｔｇ２의 다형성 및 이의 일배체를 바이오마커로 이용한 뇌졸중 진단방법 | |
| JP4657757B2 (ja) | 肺高血圧症発症関連遺伝子を用いた肺高血圧症の診断および治療 | |
| JP2001286288A (ja) | 診断法 | |
| EP1882044A1 (en) | Use of a gip promoter polymorphism | |
| JP2004522429A5 (enExample) | ||
| JP5002746B2 (ja) | 抗うつ薬に対する反応性予測に有用な遺伝子多型 | |
| JP4649163B2 (ja) | 気管支喘息の遺伝的素因検査方法 | |
| CN106086027A (zh) | 胃癌相关性miRNA标志物及其应用 | |
| US20070122803A1 (en) | Methods for the detection of polymorphisms in the human oatpf gene | |
| CN103205432B (zh) | 弥散型浅表性光线性汗孔角化症(dsap)相关基因 | |
| WO2002029097A2 (en) | Methods relating to polymorphisms in the human gpr10 gene | |
| JP2004531226A5 (enExample) | ||
| US20070243528A1 (en) | Methods for detecting polymorphisms using arms or rflp | |
| KR100695147B1 (ko) | 다중좌 마커를 이용한 2형 당뇨병의 진단방법, 2형당뇨병과 연관된 마커를 포함하는 폴리뉴클레오티드 및마이크로어레이 | |
| WO2003104381A2 (en) | Methods | |
| US20060263817A1 (en) | Genetic polymorphism associated with myocardial infarction and uses thereof |